Natixis’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-15,671
| Closed | -$871K | – | 1147 |
|
|
2024
Q3 | $871K | Buy |
+15,671
| New | +$871K | ﹤0.01% | 536 |
|
|
2023
Q4 | – | Sell |
-33,100
| Closed | -$1.18M | – | 1129 |
|
|
2023
Q3 | $1.18M | Sell |
33,100
-31,600
| -49% | -$1.13M | 0.01% | 467 |
|
|
2023
Q2 | $2.98M | Buy |
+64,700
| New | +$2.98M | 0.02% | 353 |
|
|
2022
Q1 | – | Sell |
-15,863
| Closed | -$1.33M | – | 1295 |
|
|
2021
Q4 | $1.33M | Sell |
15,863
-20,143
| -56% | -$1.69M | ﹤0.01% | 868 |
|
|
2021
Q3 | $3.25M | Buy |
+36,006
| New | +$3.25M | 0.01% | 638 |
|
|
2021
Q2 | – | Sell |
-2,618
| Closed | -$298K | – | 945 |
|
|
2021
Q1 | $298K | Sell |
2,618
-162
| -6% | -$18.4K | ﹤0.01% | 1000 |
|
|
2020
Q4 | $385K | Buy |
+2,780
| New | +$385K | ﹤0.01% | 929 |
|